Central Nervous System Agents in Medicinal Chemistry
Title:ACKNOWLEDGEMENTS TO REVIEWERS
Volume: 19 Issue: 3
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, ACKNOWLEDGEMENTS TO REVIEWERS, Central Nervous System Agents in Medicinal Chemistry 2019; 19 (3) . https://dx.doi.org/10.2174/187152491903191031112919
DOI https://dx.doi.org/10.2174/187152491903191031112919 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
13
1
1
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tetrahydroxystilbene Glucoside Improves Neurotrophic Factors Release in Cultured Astroglia
CNS & Neurological Disorders - Drug Targets Synthesis of Imidazo[1,2-b]pyridazine Comprised Piperazine, Morpholine Derivatives as Potent Antimycobacterial Agents with In Vivo Locomotor Activity
Anti-Infective Agents Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer’s Disease
Current Neurovascular Research Using Microgravity for Defining Novel Anti-Atherosclerotic Therapy
Current Genomics Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain
Current Medicinal Chemistry Ageing and Nutritional Therapy Adherence in Type 2 Diabetes
Current Diabetes Reviews Emerging Role of NF-κB in the Pathogenesis of Hepatic Encephalopathy
Current Signal Transduction Therapy Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia
Current Cancer Drug Targets Hereditary Haemorrhagic Telangiectasia: A Rare Disease As A Model for the Study of Human Atherosclerosis
Current Pharmaceutical Design Models of Parkinson’s Disease with Special Emphasis on Drosophila melanogaster
CNS & Neurological Disorders - Drug Targets Commentary: Recalling Memory by Brain Stimulation
CNS & Neurological Disorders - Drug Targets In-Silico Identification of Drug Lead Molecule Against Pesticide Exposed-neurodevelopmental Disorders Through Network-Based Computational Model Approach
Current Bioinformatics Development ofNovel Compounds to Treat Autoimmune and Inflammatory Diseases and Graft Versus Host Reactions
Endocrine, Metabolic & Immune Disorders - Drug Targets Assessment and Relevance of Carotid Intima-Media Thickness (C-IMT) in Primary and Secondary Cardiovascular Prevention
Current Pharmaceutical Design Dosage and Passage Dependent Neuroprotective Effects of Exosomes Derived from Rat Bone Marrow Mesenchymal Stem Cells: An In Vitro Analysis
Current Gene Therapy MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders
Current Genomics Acute Tonsillitis
Infectious Disorders - Drug Targets Annona sp: Plants with Multiple Applications as Alternative Medicine - A Review
Current Bioactive Compounds Gold Nanomaterials: From Preparation to Pharmaceutical Design and Application
Current Pharmaceutical Design Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review
Current Pharmaceutical Design